Inhibikase Therapeutics, Inc.’s IKT share price has dipped by 13.59%, which has investors questioning if this is right time ...

KLP Kapitalforvaltning AS purchased a new stake in Gibraltar Industries, Inc. (NASDAQ:ROCK – Free Report) during the fourth ...

Every investor in Inhibikase Therapeutics, Inc. (NASDAQ:IKT) should be aware of the most powerful shareholder groups. We can see that hedge funds own the lion's share in the company with 31% ownership ...

H.C. Wainwright analyst Edward White reiterated a Hold rating on Inhibikase Therapeutics (IKT – Research Report) today. The company’s shares ...

Following successful mining tests by U.S. consortia and pioneering environmental impact assessment by the National Oceanic and Atmospheric Administration (NOAA) in the Clarion Clipperton Zone (CCZ) in ...

New Leadership and Focus on Advancement of IkT-001 into a Late-Stage Clinical Trial Program in Pulmonary Arterial ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

INHIBIKASE THERAPEUTICS ($IKT) is expected to release its quarterly earnings data on Tuesday, March 25th after market close, per Finnhub. Analysts are expecting ...

On Friday, Jefferies initiated coverage on Inhibikase Therapeutics Inc (NASDAQ:IKT) shares with a Buy rating and set a price ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...